A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
Clinical trial NCT06564324 · RECRUITING
Trial details
- NCT number
- NCT06564324
- Sponsor
- Nuvation Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-27
- Primary completion
- 2029-01-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.